联合TITE-CRM:对于具有迟发安全性和活动结果的疗法进行剂量检测研究的设计
Helen Barnett1,2, Oliver Boix3, Dimitris Kontos3,4
1MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
Statistics in biopharmaceutical research
|January 29, 2025
概括
本研究引入了联合时间到事件连续重新评估方法 (TITE-CRM),用于在癌症试验中找到最佳生物剂量 (OBD). 新方法有效地处理晚发性毒性和活性,优于现有设计.
科学领域:
- 临床试验方法论 临床试验方法论
- 生物统计学 生物统计学
- 制药指标 (Pharmacometrics) 是一个指标.
背景情况:
- I/II期试验旨在确定最佳生物剂量 (OBD),平衡安全性和有效性.
- 癌症治疗涉及多个周期,因延迟毒性和活性结果而使OBD确定复杂化.
- 现有的方法很难在剂量确定研究中充分解决晚发病,双变异的结果.
研究的目的:
- 引入和评估联合TITE-CRM,一种新的基于模型的剂量确定试验设计.
- 专门解决晚发性毒性和癌症治疗中的活性所带来的挑战.
- 提供一个直观和计算可行的设计,优于当前的替代方案.
主要方法:
- 开发联合TITE-CRM,扩展已建立的TITE-CRM框架.
- 纳入基于模型的方法,同时分析晚发性毒性和活性数据.
- 与现有设计对晚发症双变异结果的比较评估.
主要成果:
- 与当前的替代设计相比,联合TITE-CRM表现出优越的性能.
- 该模型有效地解释了晚发性毒性和活性的复杂性.
- 拟议的设计既是直观的,也是可用于临床应用的计算可行的.
结论:
- 联合TITE-CRM提供了在癌症临床试验中识别OBD的改进方法.
- 这种设计增强了管理晚发性毒性和活性的能力,这对于有效的癌症治疗至关重要.
- 联合TITE-CRM代表了瘤学适应性临床试验设计的重大进展.
更多相关视频
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
2.7K
08:22Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
Published on: October 7, 2017
8.0K
相关概念视频
Structure-Activity Relationships and Drug Design
493
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
493
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
115
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
115
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
